Skip to main content

Thrombin Preconditioning Attenuates Iron-Induced Neuronal Death

  • Chapter
  • First Online:
Intracerebral Hemorrhage Research

Part of the book series: Acta Neurochirurgica Supplementum ((NEUROCHIRURGICA,volume 111))

Abstract

Pretreatment with a low dose of thrombin attenuated brain injury after intracerebral hemorrhage (ICH) or cerebral ischemia. This phenomenon has been called thrombin preconditioning (TPC). The current study investigated whether or not TPC reduces neuronal death induced by iron in cultured neurons. The roles of protease-activated receptors (PARs) and the p44/42 mitogen-activated protein kinase (p44/42MAPK)/70-kDa ribosomal protein S6 kinase (p70S6K) signal transduction pathway in TPC were also examined. This study had three parts: (1) primary cultured neurons were pretreated with vehicle, thrombin or PAR agonists. Cell death was induced by ferrous iron (500 μM) 24 h later. After 48 h, culture medium was collected for lactate dehydrogenase measurement; (2)neurons were treated with vehicle, thrombin or thrombin plus PPACK (D-Phe-Pro-Arg chloromethylketone) thrombin and were collected for Western blotting; (3)the effect PD098059 on TPC was examined. Cells were treated with 20 μM PD098059 or vehicle 1 h before TPC. Neuron viability was measured 24 h following exposure to ferrous iron. Preconditioning with thrombin or PAR agonists reduced iron-induced neuronal death (p < 0.05). Thrombin, but not PPACK thrombin, upregulated the protein levels of activated p44/42 MAPK and p70 S6K (p < 0.05) in neurons. PD098059 also abolished the TPC-induced neuronal protection against iron (p < 0.05). In conclusion, the protective effect of thrombin preconditioning is partially achieved through activating PARs and the p44/42 MAPK/p70S6K signal transduction pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Cannon JR, Keep RF, Hua Y, Richardson RJ, Schallert T, Xi G (2005) Thrombin preconditioning provides protection in a 6-hydroxydopamine Parkinson’s disease model. Neurosci Lett 373:189–194

    Article  PubMed  CAS  Google Scholar 

  2. Choi SH, da Lee Y, Kim SU, Jin BK (2005) Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J Neurosci 25:4082–4090

    Article  PubMed  CAS  Google Scholar 

  3. Choi SH, da Lee Y, Ryu JK, Kim J, Joe EH, Jin BK (2003) Thrombin induces nigral dopaminergic neurodegeneration in vivo by altering expression of death-related proteins. Neurobiol Dis 14:181–193

    Article  PubMed  CAS  Google Scholar 

  4. Henrich-Noack P, Striggow F, Reiser G, Reymann KG (2006) Preconditioning with thrombin can be protective or worsen damage after endothelin-1-induced focal ischemia in rats. J Neurosci Res 83:469–475

    Article  PubMed  CAS  Google Scholar 

  5. Hua Y, Keep R, Hoff J, Xi G (2007) Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 38:759–762

    Article  PubMed  CAS  Google Scholar 

  6. Hua Y, Keep RF, Hoff JT, Xi G (2003) Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab 23:1448–1454

    Article  PubMed  CAS  Google Scholar 

  7. Jiang Y, Wu J, Hua Y, Keep RF, Xiang J, Hoff JT, Xi G (2002) Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab 22:404–410

    Article  PubMed  CAS  Google Scholar 

  8. Masada T, Xi G, Hua Y, Keep RF (2000) The effects of thrombin preconditioning on focal cerebral ischemia in rats. Brain Res 867:173–179

    Article  PubMed  CAS  Google Scholar 

  9. Striggow F, Riek M, Breder J, Henrich-Noack P, Reymann KG, Reiser G (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97:2264–2269

    Article  PubMed  CAS  Google Scholar 

  10. Vaughan PJ, Pike CJ, Cotman CW, Cunningham DD (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J Neurosci 15:5389–5401

    PubMed  CAS  Google Scholar 

  11. Xi G, Hua Y, Keep RF, Hoff JT (2000) Induction of colligin may attenuate brain edema following intracerebral hemorrhage. Acta Neurochir Suppl 76:501–505

    PubMed  CAS  Google Scholar 

  12. Xi G, Keep RF, Hua Y, Xiang JM, Hoff JT (1999) Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30:1247–1255

    PubMed  CAS  Google Scholar 

  13. Yang S, Hua Y, Nakamura T, Keep RF, Xi G (2006) Up-regulation of brain ceruloplasmin in thrombin preconditioning. Acta Neurochir Suppl 96:203–206

    Article  PubMed  CAS  Google Scholar 

  14. Cannon JR, Keep RF, Schallert T, Hua Y, Richardson RJ, Xi G (2006) Protease-activated receptor-1 mediates protection elicited by thrombin preconditioning in a rat 6-hydroxydopamine model of Parkinson’s disease. Brain Res 1116:177–186

    Article  PubMed  CAS  Google Scholar 

  15. Gidday JM (2010) Pharmacologic preconditioning: translating the promise. Transl Stroke Res 1:19–30

    Article  PubMed  CAS  Google Scholar 

  16. Keep RF, Wang MM, Xiang J, Hua Y, Xi G (2010) Is there a place for cerebral preconditioning in the clinic? Transl Stroke Res 1:4–18

    Article  PubMed  CAS  Google Scholar 

  17. Dirnagl U, Simon RP, Hallenbeck JM (2003) Ischemic tolerance and endogenous neuroprotection. Trends Neurosci 26:248–254

    Article  PubMed  CAS  Google Scholar 

  18. Gidday JM (2006) Cerebral preconditioning and ischaemic tolerance. Nat Rev Neurosci 7:437–448

    Article  PubMed  CAS  Google Scholar 

  19. Hausenloy DJ, Mocanu MM, Yellon DM (2004) Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res 63:305–312

    Article  PubMed  CAS  Google Scholar 

  20. Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM (2005) Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol Heart Circ Physiol 288:H971–H976

    Article  PubMed  CAS  Google Scholar 

  21. Berven LA, Crouch MF (2000) Cellular function of p70S6K: a role in regulating cell motility. Immunol Cell Biol 78:447–451

    Article  PubMed  CAS  Google Scholar 

  22. Hua Y, Xi G, Keep RF, Wu J, Jiang Y, Hoff JT (2002) Plasminogen activator inhibitor-1 induction after experimental intracerebral hemorrhage. J Cereb Blood Flow Metab 22:55–61

    Article  PubMed  CAS  Google Scholar 

  23. Xi G, Reiser G, Keep RF (2003) The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J Neurochem 84:3–9

    Article  PubMed  CAS  Google Scholar 

  24. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258–264

    Article  PubMed  CAS  Google Scholar 

  25. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, Dawson VL (2000) Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc Natl Acad Sci USA 97:436–441

    Article  PubMed  CAS  Google Scholar 

  26. Kis A, Yellon DM, Baxter GF (2003) Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. J Mol Cell Cardiol 35:1063–1071

    Article  PubMed  CAS  Google Scholar 

  27. Malhotra S, Savitz SI, Ocava L, Rosenbaum DM (2006) Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83:19–27

    Article  PubMed  CAS  Google Scholar 

  28. Wynne AM, Mocanu MM, Yellon DM (2005) Pioglitazone mimics preconditioning in the isolated perfused rat heart: a role for the prosurvival kinases PI3K and P42/44MAPK. J Cardiovasc Pharmacol 46:817–822

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

This study was supported by grants NS-017760, NS-039866 and NS-057539 from the National Institutes of Health (NIH) and 0840016N from the American Heart Association (AHA). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH and AHA.

Conflict of interest statement We declare that we have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Guohua Xi .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag/Wien

About this chapter

Cite this chapter

Hu, H., Yamashita, S., Song, S., Hua, Y., Keep, R.F., Xi, G. (2011). Thrombin Preconditioning Attenuates Iron-Induced Neuronal Death. In: Zhang, J., Colohan, A. (eds) Intracerebral Hemorrhage Research. Acta Neurochirurgica Supplementum, vol 111. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0693-8_43

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0693-8_43

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0692-1

  • Online ISBN: 978-3-7091-0693-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics